NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

憩室炎 - 流行病學考察:2030年

Diverticulitis - Epidemiology Insight - 2030

出版商 DelveInsight Business Research LLP 商品編碼 966776
出版日期 按訂單生產 內容資訊 英文 100 Pages
商品交期: 10個工作天內
價格
憩室炎 - 流行病學考察:2030年 Diverticulitis - Epidemiology Insight - 2030
出版日期: 按訂單生產內容資訊: 英文 100 Pages
簡介

本報告提供憩室炎調查分析,過去、未來的流行病學,以美國、歐洲5個國家 (德國,西班牙,義大利,法國,英國) 、日本的市場趨勢為焦點,提供治療流程、治療指南,流行病學方案相關的系統性資訊。

目錄

第1章 主要考察

第2章 憩室炎的摘要整理

第3章 憩室炎:疾病的背景和概要

  • 簡介
  • 徵兆與症狀
  • 病理生理學
  • 危險因素
  • 診斷

第4章 病人歷程

第5章 流行病學和患者族群

  • 流行病學的主要調查結果
  • 前提條件與根據:主要7個國家
  • 流行病學方案:主要7個國家
  • 美國的流行病學
  • 歐洲5個國家的各國流行病學
  • 日本的流行病學

第6章 治療流程,目前治療,醫療行為

  • 憩室炎的治療和管理
  • 憩室炎的治療流程

第7章 KOL的見解

第8章 未滿足需求

第9章 附錄

第10章 DelveInsight的服務內容

第11章 免責聲明

第12章 關於DelveInsight

目錄
Product Code: DIEI1051

DelveInsight's 'Diverticulitis - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Diverticulitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Diverticulitis Understanding

The DelveInsight Diverticulitis epidemiology report gives a thorough understanding of the Diverticulitis by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Diverticulitis in the US, Europe, and Japan. The report covers the detailed information of the Diverticulitis epidemiology scenario in seven major countries (US, EU5, and Japan).

Diverticulitis Epidemiology Perspective by DelveInsight

The Diverticulitis epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Diverticulitis epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Diverticulitis epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Diverticulitis Detailed Epidemiology Segmentation

The Diverticulitis epidemiology covered in the report provides historical as well as forecasted Diverticulitis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Diverticulitis report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report:

  • The Diverticulitis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Diverticulitis Epidemiology Report and Model provide an overview of the risk factors and global trends of Diverticulitis in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Diverticulitis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Diverticulitis
  • The report provides the segmentation of the Diverticulitis epidemiology

Report Highlights:

  • 11-Year Forecast of Diverticulitis epidemiology
  • 7MM Coverage
  • Total Cases of Diverticulitis
  • Total Cases of Diverticulitis according to segmentation
  • Diagnosed cases of Diverticulitis

KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Diverticulitis ?
  • What are the key findings pertaining to the Diverticulitis epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Diverticulitis across the 7MM during the forecast period (2017-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Diverticulitis ?
  • What are the currently available treatments of Diverticulitis ?

Reasons to buy:

  • The Diverticulitis Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Diverticulitis market
  • Quantify patient populations in the global Diverticulitis market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Diverticulitis therapeutics in each of the markets covered
  • Understand the magnitude of Diverticulitis population by its epidemiology
  • The Diverticulitis Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Executive Summary of Diverticulitis

3. Diverticulitis : Disease Background and Overview

  • 3.1. Introduction
  • 3.2. Sign and Symptoms
  • 3.3. Pathophysiology
  • 3.4. Risk Factors
  • 3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

  • 5.1. Epidemiology Key Findings
  • 5.2. Assumptions and Rationale: 7MM
  • 5.3. Epidemiology Scenario: 7MM
    • 5.3.1. Diverticulitis Epidemiology Scenario in the 7MM (2017- 2030)
  • 5.4. United States Epidemiology
    • 5.4.1. Diverticulitis Epidemiology Scenario in the United States (2017- 2030)
  • 5.5. EU-5 Country-wise Epidemiology
    • 5.5.1. Germany Epidemiology
      • 5.5.1.1. Diverticulitis Epidemiology Scenario in Germany (2017- 2030)
    • 5.5.2. France Epidemiology
      • 5.5.2.1. Diverticulitis Epidemiology Scenario in France (2017- 2030)
    • 5.5.3. Italy Epidemiology
      • 5.5.3.1. Diverticulitis Epidemiology Scenario in Italy (2017- 2030)
    • 5.5.4. Spain Epidemiology
      • 5.5.4.1. Diverticulitis Epidemiology Scenario in Spain (2017- 2030)
    • 5.5.5. United Kingdom Epidemiology
      • 5.5.5.1. Diverticulitis Epidemiology Scenario in the United Kingdom (2017-2030)
  • 5.6. Japan Epidemiology
    • 5.6.1. Diverticulitis Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

  • 6.1. Diverticulitis Treatment and Management
  • 6.2. Diverticulitis Treatment Algorithm

7. KOL Views

8. Unmet Needs

9. Appendix

  • 9.1. Bibliography
  • 9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

The table of contents is not exhaustive; will be provided in the final report

List of Tables

  • Table 1: Diverticulitis Epidemiology in 7MM (2017-2030)
  • Table 2: Diverticulitis Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Table 3: Diverticulitis Epidemiology in the United States (2017-2030)
  • Table 4: Diverticulitis Diagnosed and Treatable Cases in the United States (2017-2030)
  • Table 5: Diverticulitis Epidemiology in Germany (2017-2030)
  • Table 6: Diverticulitis Diagnosed and Treatable Cases in Germany (2017-2030)
  • Table 7: Diverticulitis Epidemiology in France (2017-2030)
  • Table 8: Diverticulitis Diagnosed and Treatable Cases in France (2017-2030)
  • Table 9: Diverticulitis Epidemiology in Italy (2017-2030)
  • Table 10: Diverticulitis Diagnosed and Treatable Cases in Italy (2017-2030)
  • Table 11: Diverticulitis Epidemiology in Spain (2017-2030)
  • Table 12: Diverticulitis Diagnosed and Treatable Cases in Spain (2017-2030)
  • Table 13: Diverticulitis Epidemiology in the United Kingdom (2017-2030)
  • Table 14: Diverticulitis Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Table 15: Diverticulitis Epidemiology in Japan (2017-2030)
  • Table 16: Diverticulitis Diagnosed and Treatable Cases in Japan (2017-2030)

List of Figures

  • Figure 1: Diverticulitis Epidemiology in 7MM (2017-2030)
  • Figure 2: Diverticulitis Diagnosed and Treatable Cases in 7MM (2017-2030)
  • Figure 3: Diverticulitis Epidemiology in the United States (2017-2030)
  • Figure 4: Diverticulitis Diagnosed and Treatable Cases in the United States (2017-2030)
  • Figure 5: Diverticulitis Epidemiology in Germany (2017-2030)
  • Figure 6: Diverticulitis Diagnosed and Treatable Cases in Germany (2017-2030)
  • Figure 7: Diverticulitis Epidemiology in France (2017-2030)
  • Figure 8: Diverticulitis Diagnosed and Treatable Cases in France (2017-2030)
  • Figure 9: Diverticulitis Epidemiology in Italy (2017-2030)
  • Figure 10: Diverticulitis Diagnosed and Treatable Cases in Italy (2017-2030)
  • Figure 11: Diverticulitis Epidemiology in Spain (2017-2030)
  • Figure 12: Diverticulitis Diagnosed and Treatable Cases in Spain (2017-2030)
  • Figure 13: Diverticulitis Epidemiology in the United Kingdom (2017-2030)
  • Figure 14: Diverticulitis Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
  • Figure 15: Diverticulitis Epidemiology in Japan (2017-2030)
  • Figure 16: Diverticulitis Diagnosed and Treatable Cases in Japan (2017-2030)

The table of contents is not exhaustive; will be provided in the final report